• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国国家骨质疏松症风险评估计划(NORA)的设计:一项针对绝经后女性的美国纵向登记研究。

Design of NORA, the National Osteoporosis Risk Assessment Program: a longitudinal US registry of postmenopausal women.

作者信息

Siris E, Miller P, Barrett-Connor E, Abbott T, Sherwood L, Berger M

机构信息

Columbia University, College of Physicians and Surgeons, New York, New York, USA.

出版信息

Osteoporos Int. 1998;8 Suppl 1:S62-9.

PMID:9682801
Abstract

NORA is an observational registry of postmenopausal US women with periodic collection of event and treatment data that will create a database including several hundred thousand subjects. It will utilize peripheral and central measurements of bone density and relate these to other risk factors, treatment patterns, and the natural history of osteoporosis. Initiated in the fall of 1997, the registry will be open to women throughout the United States who agree to complete baseline and on-going surveys. The database created by NORA will provide a resource that is unmatched in size and scope in the medical field and will allow for future research in a number of areas including patient outcomes, types of follow-up employed in clinical practice, diagnostic cost modelling, and osteoporosis therapy use (type, patient compliance, persistence and satisfaction). In addition, upon approval by the Steering Committee, women enrolled in the registry may be randomly selected to receive additional educational materials or questionnaires on a variety of topics of interest to specific researchers.

摘要

NORA是一项针对美国绝经后女性的观察性登记研究,定期收集事件和治疗数据,将创建一个包含几十万受试者的数据库。它将利用外周和中心骨密度测量,并将这些与其他风险因素、治疗模式以及骨质疏松症的自然病史相关联。该登记研究于1997年秋季启动,将对全美国同意完成基线调查和持续调查的女性开放。NORA创建的数据库将提供一个在医学领域规模和范围无与伦比的资源,并将允许在包括患者结局、临床实践中采用的随访类型、诊断成本建模以及骨质疏松症治疗使用(类型、患者依从性、持续性和满意度)等多个领域进行未来研究。此外,经指导委员会批准,登记研究中的女性可能会被随机选中,以接收针对特定研究人员感兴趣的各种主题的额外教育材料或问卷。

相似文献

1
Design of NORA, the National Osteoporosis Risk Assessment Program: a longitudinal US registry of postmenopausal women.美国国家骨质疏松症风险评估计划(NORA)的设计:一项针对绝经后女性的美国纵向登记研究。
Osteoporos Int. 1998;8 Suppl 1:S62-9.
2
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.预防性卵巢切除术:降低美国上皮性卵巢癌死亡率。一场持续的争论。
Oncologist. 1996;1(5):326-330.
3
Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.绝经后激素治疗的近期使用情况及持续时间:在国家骨质疏松症风险评估(NORA)研究中对骨矿物质密度和骨折风险的影响。
Menopause. 2003 Sep-Oct;10(5):412-9. doi: 10.1097/01.GME.0000086467.82759.DA.
4
[Raloxifene in clinical practice. Results of the non-interventional study CORAL (COmpliance with RALoxifene)].[临床实践中的雷洛昔芬。非干预性研究CORAL(雷洛昔芬依从性研究)的结果]
Vnitr Lek. 2008 Mar;54(3):217-9, 221-4.
5
Use of a Swedish T-score reference population for women causes a two-fold increase in the amount of postmenopausal Swedish patients that fulfill the WHO criteria for osteoporosis.将瑞典女性的T评分参考人群用于判定,会使符合世界卫生组织骨质疏松症标准的瑞典绝经后患者数量增加一倍。
J Clin Densitom. 2008 Jul-Sep;11(3):404-11. doi: 10.1016/j.jocd.2007.12.014. Epub 2008 Feb 15.
6
Bone mineral density thresholds for pharmacological intervention to prevent fractures.预防骨折的药物干预的骨密度阈值。
Arch Intern Med. 2004 May 24;164(10):1108-12. doi: 10.1001/archinte.164.10.1108.
7
A claims database analysis of persistence with alendronate therapy and fracture risk in post-menopausal women with osteoporosis.一项关于绝经后骨质疏松症女性阿仑膦酸盐治疗持续性与骨折风险的索赔数据库分析。
Curr Med Res Opin. 2007 Mar;23(3):585-94. doi: 10.1185/030079906X167615.
8
Risk factors for clinical fractures among postmenopausal women: a 10-year prospective study.绝经后女性临床骨折的危险因素:一项为期10年的前瞻性研究。
Menopause Int. 2007 Sep;13(3):110-5. doi: 10.1258/175404507781605668.
9
The role of the primary care physician in diagnosis and management of osteoporosis.初级保健医生在骨质疏松症诊断与管理中的作用。
Int J Fertil Womens Med. 2002 May-Jun;47(3):116-22.
10
Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis.低骨量或骨质疏松绝经后妇女的骨量、浸润性乳腺癌发病率与雷洛昔芬治疗之间的关系
Curr Med Res Opin. 2008 Mar;24(3):807-13. doi: 10.1185/030079908X273282. Epub 2008 Feb 5.

引用本文的文献

1
Racial and Ethnic Disparities in Bone Health and Outcomes in the United States.美国骨骼健康和结局的种族和民族差异。
J Bone Miner Res. 2021 Oct;36(10):1881-1905. doi: 10.1002/jbmr.4417. Epub 2021 Oct 7.
2
Comparing the T scores from bone sonometer measurements in Hispanic and non-Hispanic white women.比较西班牙裔和非西班牙裔白人女性骨超声测量的T值。
Pharm Pract (Granada). 2006 Oct;4(4):179-82. doi: 10.4321/s1885-642x2006000400005.
3
Risk for osteoporosis in elderly nuns: need for better recognition and treatment.老年修女患骨质疏松症的风险:需要更好的识别与治疗。
Curr Ther Res Clin Exp. 2003 Feb;64(2):65-80. doi: 10.1016/S0011-393X(03)00017-1.
4
Osteoporosis and type 2 diabetes mellitus: what do we know, and what we can do?骨质疏松症与2型糖尿病:我们了解什么,又能做些什么?
Patient Prefer Adherence. 2012;6:435-48. doi: 10.2147/PPA.S32745. Epub 2012 Jun 11.
5
Rib fracture as a predictor of future fractures in young and older postmenopausal women: National Osteoporosis Risk Assessment (NORA).肋骨骨折是年轻和老年绝经后妇女未来骨折的预测指标:国家骨质疏松风险评估(NORA)。
Osteoporos Int. 2012 Mar;23(3):821-8. doi: 10.1007/s00198-011-1757-0. Epub 2011 Sep 9.
6
A population-based study on trend in incidence of distal radial fractures in adults in Taiwan in 2000-2007.一项基于人群的研究,旨在探讨 2000-2007 年台湾地区成年人远端桡骨骨折发病率的变化趋势。
Osteoporos Int. 2011 Nov;22(11):2809-15. doi: 10.1007/s00198-010-1489-6. Epub 2010 Nov 25.
7
The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design.《女性骨质疏松全球纵向研究(GLOW)》:基本原理与研究设计。
Osteoporos Int. 2009 Jul;20(7):1107-16. doi: 10.1007/s00198-009-0958-2. Epub 2009 May 26.
8
Associations between methotrexate treatment and methylenetetrahydrofolate reductase gene polymorphisms with incident fractures in Japanese female rheumatoid arthritis patients.甲氨蝶呤治疗与亚甲基四氢叶酸还原酶基因多态性与日本女性类风湿关节炎患者骨折发生率之间的关联。
J Bone Miner Metab. 2009;27(5):574-83. doi: 10.1007/s00774-009-0073-7. Epub 2009 Mar 31.
9
Greater osteoporosis educational outreach is desirable among Chinese immigrants in Chinatown, Chicago.在芝加哥唐人街的中国移民中,更需要开展骨质疏松症教育外展活动。
Osteoporos Int. 2009 Sep;20(9):1517-22. doi: 10.1007/s00198-008-0828-3. Epub 2009 Jan 16.
10
Design of the POSSIBLE UStrade mark Study: postmenopausal women's compliance and persistence with osteoporosis medications.POSSIBLE 商标研究的设计:绝经后妇女对骨质疏松症药物的依从性和持久性。
Osteoporos Int. 2009 Mar;20(3):463-72. doi: 10.1007/s00198-008-0674-3. Epub 2008 Jul 8.